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Sacral and presacral tumors are uncommon. Rasmuss-
en, et al.,26 found only 35 (7%) of 557 intraspinal tumors
involving the sacrum. It has been estimated that these tu-
mors occur in only one of 40,000 hospital admissions, but
they are probably even more rare.40
Nerve sheath tumors comprise only a small portion of
the wide variety of lesions that occur in the sacral region.39
In two reviews of more than 250 sacral and presacral tu-
mors, the authors found only one NST.21,28 These tumors
can often reach enormous dimensions before producing
neurological symptoms and are difficult to diagnose at an
early stage. The vast majority of sacral NSTs are schwan-
nomas. En bloc resection is the treatment of choice. Be-
cause of their size and the presence of critical sacral nerve
roots, however, this is often difficult and usually requires
a team approach involving neurosurgeons and general sur-
geons. We discuss the recent case of a patient treated at
our institution and report on the presentation, diagnosis,
pathological features, and management of these rare
spinal pathological entities.
CASE REPORT 
Presentation. This 25-year-old woman was involved
in a motor vehicle accident in which she sustained numer-
ous injuries including a severe head injury. As part of the
routine evaluation, she underwent imaging studies that
revealed a pelvic mass. Prior to her accident, the patient
had suffered mild low-back pain radiating bilaterally to
her quadriceps as well as episodes of urinary inconti-
nence; other features had also been suggestive of an aton-
ic bladder. 
Examination. Initial studies included an anteroposterior
pelvic radiograph and an abdominal/pelvic CT scan. The
plain radiograph demonstrated enlarged left sacral foram-
ina (Fig. 1). The CT scan revealed a 9 ✁ 6 ✁ 6–cm heter-
ogeneous calcified mass in the left pelvis emanating from
the sacrum with concomitant osseous changes (Fig. 2). An
MR imaging study suggested that the contrast-enhancing
tumor originated from the S-2 nerve root (Fig. 3). 
Operations. After almost 1 year of rehabilitation for her
head injury, the patient was ready to undergo surgery. The
tumor was first approached posteriorly through a midline,
multilevel sacral laminectomy. The lamina had been sig-
nificantly eroded by the mass. The intracanalicular portion
of the tumor was carefully resected, and we periodically
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Nerve sheath tumors that involve the sacrum are rare. Delayed presentation is common because of their slow-grow-
ing nature, the permissive surrounding anatomical environment, and nonspecific symptoms. Consequently, these
tumors are usually of considerable size at the time of diagnosis. 
The authors discuss a case of a sacral nerve sheath tumor. They also propose a classification scheme for these tumors
based on their location with respect to the sacrum into three types (Types I–III). Type I tumors are confined to the
sacrum; Type II originate within the sacrum but then locally metastasize through the anterior and posterior sacral walls
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Abbreviations used in this paper: CT = computerized tomogra-
phy; EMG = electromyography; MR = magnetic resonance; NST =
nerve sheath tumor.
used a nerve stimulator and EMG to identify neural struc-
tures. Intradural exploration did not reveal tumor. One
month later, a transabdominal approach was used to excise
the presacral portion of the tumor. A midline incision was
made from the umbilicus to the pubic bone. On entering
the peritoneal cavity, the retroperitoneal space containing
the mass was opened. A nerve stimulator and EMG were
again used. Much of the tumor’s capsule contained neu-
ral structures. The S-2 nerve root was found to enter
the tumor eccentrically at its superior pole. A safe entry
point was identified, and the tumor was debulked inter-
nally. With careful dissection, a gross-total resection was
achieved. 
Histological Examination. The patient’s tumor was
shown to be a classic schwannoma. It exhibited mild pleo-
morphism, varying degrees of cellularity, rare mitotic fig-
ures, and both Antoni A and B patterns. 
Postoperative Course. The patient recovered well from
her surgeries. She regained normal sphincter function and
suffered no motor or sensory deficits. She underwent a re-
peated MR imaging study 1 year postoperatively, which
revealed no recurrence.
CLINICAL MANIFESTATIONS 
In most patients signs and symptoms have manifested
by presentation because of the long period of latency since
onset. The mean duration of symptoms ranges from 1 to 7
years.1,3,6,7,36 There is a report of a patient harboring a tu-
mor for more than 25 years before the onset of symp-
toms.16 The constellation of signs and/or symptoms is sim-
ilar for tumors that arise within the sacrum and extend into
the pelvis and those that originate anterior to the sacrum
and subsequently erode into the sacrum, regardless of his-
tology. Pain is the most common presenting symptom and
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Fig. 1. Plain anteroposterior pelvic radiograph demonstrating a
large asymmetrical lytic lesion of the left sacrum (arrowheads).
Fig. 2. Axial bone window CT scan revealing a large left sacral
mass expanding into the presacral space. Note the markedly en-
larged left neural foramen compared with the normal one on the
right. The sclerotic margins suggest that the mass is slow growing
and has been present for some time.
Fig. 3. Magnetic resonance images. Upper: Contrast-en-
hanced sagittal image revealing the intra- and presacral compo-
nents of the tumor. Note the marked enhancement of the intrasacral
portion compared with the presacral. Center: Axial image dem-
onstrating the same features. Lower: Coronal image.
may be localized low-back or radicular pain, extending
in the distribution of one or more lumbar or sacral
roots.1,3,6,7,38 Sensory symptoms include paresthesias and
dysesthesias. Urinary hesitancy, retention, weak stream
and overflow, and unconscious incontinence are present in
patients with an acontractile bladder. Patients may present
with repeated bouts of cystitis.3 A neurogenic bladder
must be ruled out in patients, especially males, who pre-
sent with repeated urinary tract infections and no obvious
cause. Some patients complain of constipation and an
unpleasant feeling of rectal fullness or pain.7,19
Signs include lower-extremity weakness, atrophy, de-
creased deep tendon reflexes (particularly the Achilles),
and diminished saddle and lower-extremity sensation.
One of the most important physical examination maneu-
vers in patients with a suspected sacral mass is the digital
rectal evaluation. The mass is often palpable and may pro-
vide the physician with a more limited differential diag-
nosis.36 Developmental enteric cysts are usually in the
midline, soft, and nontender. Anterior sacral meningoceles
are also midline, soft, and may cause headache or cough
on palpation. Chordomas are often irregular and solid. In-
flammatory lesions are often painful. Finally, NSTs are
firm, smooth, and often off the midline. 
IMAGING FEATURES 
A wide variety of pathological masses may involve the
sacrum: chordomas, giant cell tumors, osteoblastomas,
plasmacytomas, lymphomas, chondrosarcomas, terato-
mas, inflammatory and congenital lesions, anterior menin-
goceles, neuroblastomas, and aneurysmal bone cysts.39
Nerve sheath tumors may arise from the within the sacrum
or anterior to it in the presacral/retroperitoneal space. Prior
to the CT/MR imaging era, plain pelvic radiography was
the only available imaging modality. Features such as lytic
lesions, distortion, and expansion of the normal sacral an-
atomy, enlargement of sacral neural foramina, and ab-
normal calcifications are present in almost all patients.
Overlying bowel shadows can obscure details, however,
especially when the tumor causes hypomotility of the
bowels.18,19,39 Many patients will undergo a barium enema
on the presumption that the mass represents a primary
enteric entity. 
A more complete and detailed assessment of the sacrum
is provided by CT scanning. It also demonstrates the rela-
tionship between the tumor and anatomical structures
within the pelvis. Sagittal and coronal CT reconstructions
provide added detail. Lesions adjacent to the sacrum typ-
ically cause anterior sacral erosion, whereas one arising
from within the sacral canal causes erosion of both the
anterior and posterior sacral borders as well as expansion
of the sacrum.5,36 Magnetic resonance imaging provides
superior resolution of soft-tissue structures with multipla-
nar capability. Sacral NSTs do not exhibit the typical MR
imaging features characteristic of NSTs found elsewhere,
such as a fusiform shape, eccentric tumor with respect to
the host nerve, “split-fat” sign, “target” sign, and the “fas-
cicular” sign.25 Sacral NSTs are large, eccentric, well-de-
fined heterogeneous, enhancing masses. Because of their
slow growth, they may exhibit degenerative changes such
as cyst formation, hemorrhage, necrosis, and calcification.
These features are common in “ancient” or degenerative
schwannomas but rare in neurofibromas. A pseudocapsule
is often visible as a rim of hypointensity in schwannomas,
whereas only 30% of neurofibromas possess a capsule.25
Benign sacral NSTs are typically not markedly vascular;
however, malignant NSTs can be.7,9,18 Tumors in this re-
gion may be fed by multiple vascular pedicles, including
the medial and lateral sacral arteries, as well as branches
of the lumbar and internal iliac vessels. 
HISTOPATHOLOGICAL FEATURES 
The vast majority of sacral NSTs are schwannomas. In
much of the early literature, there is no differentiation be-
tween terms such as schwannoma, neurofibroma, and neu-
rilemmoma, making the exact diagnosis uncertain.3,5
Schwannomas are benign, encapsulated tumors composed
entirely of cells with the immunophenotype and ultra-
structural features of Schwann cells.32 There are numerous
schwannoma variants. In its classic form, the cells are
spindle shaped with pale, eosinophilic cytoplasms ar-
ranged in two characteristic patterns: Antoni A (“dense”)
and B (“loose”). The hallmark histological feature of a
schwannoma are the Verocay bodies. The proportion of
each pattern varies, and the interface between them may
be gradual or sudden. Although not officially considered a
specific variant, ancient schwannomas or longstanding
schwannomas often show stromal and vascular degenera-
tive changes including central tissue loss with cystic for-
mation, necrosis without nuclear pallisading, nuclear
atypia, widespread hyalinization, and calcification.20,22,32,38
Cellular schwannomas differ from the classic type in that
the dense Antoni A pattern comprises 90% or more of the
tumor area with a more uniform pattern, a lack of Verocay
bodies, and frequent lymphocytic infiltration.1,24,32 There
is one report of a sacral melanocytic schwannoma in the
literature.13
Neurofibroma is a benign nerve sheath tumor com-
posed of cells with a polymorphic cellular phenotype.
These include Schwann and perineural cells as well as
endoneurial fibroblasts. Neurofibromas are composed of
widely spaced cells with ovoid-to-thin elongate nuclei and
scant cytoplasm embedded in a mucopolysaccharide-rich,
variably collagenous matrix. The neurofibroma cells are
usually aligned along the course of nerve fibers traversing
the lesion. These rarely involve the sacral region.7,18,37
Malignant nerve sheath tumors also very rarely occur in
the sacrum.7,9,12 Again, the terminology in the literature is
confusing and involves various terms such as malignant
schwannoma and neurofibrosarcoma interchangeably.
Previous radiotherapy has also been shown to contribute
to the development of malignant NST.12 The hallmark fea-
tures of malignant NSTs include intrafascicular spread
within or beyond the main tumor mass and invasion of the
surrounding tissue. Most are surrounded by a fibrous
pseudocapsule and areas of gross necrosis. Microscopical-
ly, most are highly cellular with numerous mitoses (usual-
ly ✂ 10/hpf), pleomorphism, and necrosis. 
TREATMENT AND RESULTS 
The goal of treatment is the same for NSTs located else-
where: complete resection. This is often difficult because
of their size, robust blood supply, and proximity to elo-
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quent neurological and nonneurological structures. Ap-
proaches to these tumors may be anterior, posterior, or
combined. The approach is dictated by the amount of
intrapelvic and intrasacral involvement. A team approach
comprising a neurosurgeon, orthopedist, and an abdomen
surgeon is often needed for successful resection. Intraop-
erative EMG and nerve stimulators should always be per-
formed to verify critical neural structures. 
Presacral NSTs may arise from the retroperitoneal
space or by local extension from the sacrum. In general,
tumors with a large presacral/retroperitoneal component
should be approached anteriorly.2,4,11,20,22,24 The most sig-
nificant challenge in this approach is controlling arterial
and venous vasculature. Profuse bleeding is usually due to
tearing of the numerous delicate venous channels.1,24
Some authors believe that most of the intrasacral compo-
nent can be removed anteriorly.2 An extraperitoneal ap-
proach to the retroperitoneal space by making a right-
sided flank incision has also been described in a patient
with a predominantly presacral tumor.37
Posterior approaches are performed in cases of tumors
involving a significant intrasacral component.7,15,18,19,23,27,30
Intradural proliferation, which is usually found in tumors
with a cephalad extension, is an absolute indication for a
posterior approach.2 Similar to proponents of the anterior
approach, some authors have indicated that presacral com-
ponents, if less than 10 cm, may be removed via a poste-
rior approach.27,36
In tumors with large pre- and intrasacral components,
combined anterior–posterior surgical approaches are usu-
ally needed.1,17,38,41 This can be conducted in two stages, as
in our patient, or in a single sitting. The abdominosacral
approach allows a combined abdominal–transsacral ap-
proach.17,38 The patient is placed in a lateral decubitus
position, and the abdomen is entered through an oblique
incision starting between the iliac crest and the costal mar-
gin, running parallel to the inguinal ligament. To achieve
maximum cytological reductive surgery, total sacrectomy
is sometimes needed.31,33,35 This formidable task involves
anterior and posterior approaches and internal fixation by
fusion with L-5.31 Alternatively, a high sacral amputation
may be performed at one of two levels: between S-1 and
S-2 and through S-1.35 Such procedures, however, may
cause significant neurological deficits. Bilateral sacrifice
of all sacral nerves except the S-1 nerve will result in loss
of bowel, bladder, and sexual function.35 Ambulation
should be marginally affected. Gluteus maximus weak-
ness may be evident when climbing stairs. Most authors
agree that sparing the first three sacral nerve roots bilater-
ally or all the sacral nerves unilaterally guarantees preser-
vation of autonomic function.7,10,34,35,41,42
Core needle biopsy procedures are often performed and
have positive and negative attributes. Opponents of this
procedure have cited a high rate of inconclusive results,
the potential for misdiagnosis of a malignant neoplasm,
complications such as infection and hemorrhage, and the
possibility of tumor dissemination along the biopsy tract
as reasons not pursue it.1,4,11,18 Others have contended that
it is useful in excluding other diagnoses that would not
benefit from surgery such as lymphoma, planning a less
radical operation, and easy accessibility through the vagi-
na or rectum.7,24
Radiotherapy is generally avoided in the treatment of
benign tumors, primarily because of the risk of develop-
ing secondary neoplasms. The use of conventional exter-
nal beam radiation therapy, however, has been reported in
a patient with an incompletely excised sacral schwanno-
ma.14 More recently, stereotactic radiosurgery has become
an alternative therapy for spinal neoplasms.8,29 Although it
would not be a feasible option for most sacral NSTs, it
could conceivably be conducted to treat those tumors that
are small (✄ 3 cm) and isolated to the sacrum. 
Most articles regarding sacral NSTs are single case
reports.2,15,20,22,23,27,30,38 There are several case series, the
largest involving 13 patients.1,6,7,42 Feldenzer, et al.,7 treat-
ed nine cases with presacral extension, in four of which
NSTs were present. A combined anterior–posterior ap-
proach was performed in two patients, and the other two
underwent surgery via a posterior approach. Two patients
harbored malignant NSTs, and both died within 3 years of
diagnosis. In the other two patients gross-total resection
was achieved, and there was no evidence of recurrence.
Dominguez, et al.,6 reported on six patients who harbored
giant intrasacral schwannomas. Four patients underwent a
posterior approach, whereas the other two had a combined
procedure. Intradural extension was present in three cases.
In one patient a recurrence developed 17 years after her
initial resection.
In the series by Abernathy, et al.,1 10 patients underwent
a posterior and three an anterior approach. Intradural inva-
sion was demonstrated in four patients, requiring open
dural procedures. Gross total resection was achieved in
four patients. Of the nine patients in whom a subtotal
resection was achieved, five remained symptom free dur-
ing the study period but four (44%) required a second
operation. The disease-free interval ranged from 7 to 84
months. The second operation was anterior in three and
combined in one patient. One patient also required inter-
nal fixation. All 13 patients reported improvement in their
pain, and all were ambulatory and functional. Six patients
suffered surgery-induced neurological deficits: sensory
loss in four, bowel/bladder dysfunction in one, and the last
had both motor and autonomic deficits. Wound complica-
tions developed in three patients. 
CLASSIFICATION OF SACRAL NSTS
In reviewing the literature, we devised a straightforward
classification system for sacral nerve sheath tumors. As
stated previously, these tumors may anatomically arise
from the presacral space or within the sacrum and extend
into the presacral or posterior subcutaneous space. The
precise anatomical distribution of the tumor determines
the surgical approach (Fig. 4). We propose that a Type I
sacral NST is one that is confined to the sacrum; a Type II
has eroded either the anterior or posterior sacral wall and
spread to adjacent spaces; and a Type III is confined to the
presacral space. Thus, a Type II tumor (the most common)
would probably require a combined anterior–posterior
approach, a Type I a posterior approach, and a Type III an
anterior approach.
CONCLUSIONS
A variety of neoplasms may occur at the sacral region.
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Nerve sheath tumors, which include schwannomas, neu-
rofibromas, and malignant NSTs, comprise a small per-
centage of lesions in this area. They are characterized by
slow steady growth and vague nonspecific symptoms. The
workup involves extensive imaging studies, namely CT
and MR imaging. Type I tumors are located exclusively
within the presacral/retroperitoneal space, Type II have
both pre- and intrasacral components, and Type III are
only intrasacral. Surgery is the treatment of choice. A cure
may be achieved by gross-total resection, but this goal
should be tempered by consideration of the potential mor-
bidities, and treatment should be individualized. Surgical
approaches include anterior, posterior, and combinations
of both.
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longstanding compression. 
22. Ogose A, Hotta T, Sato S, et al: Presacral schwannoma with
purely cystic form. Spine 26:1817–1819, 2001
23. Ortolan EG, Sola CA, Gruenberg MF, et al: Giant sacral
schwannoma. A case report. Spine 21:522–526, 1996
24. Patocskai EJ, Tabatabaian M, Thomas MJ: Cellular schwanno-
ma: a rare presacral tumour. Can J Surg 45:141–144, 2002
25. Popuri R, Davies AM: MR imaging features of giant pre-sa-
cral schwannomas: a report of four cases. Eur Radiol 12:
2365–2369, 2002
26. Rasmussen TB, Kernohan JW, Adson AW: Pathologic classifi-
cation, with surgical consideration, of intraspinal tumors. Ann
Surg 111:513–530, 1940
27. Rengachary SS, O’Boynick P, Batnitzky S, et al: Giant intra-
sacral Schwannoma: case report. Neurosurgery 9:573–577,
1981
28. Ross ST: Sacral and presacral tumors. Am J Surg 76:687–693,
1948
29. Ryu S, Kim D, Martin D, et al: Image-guided spinal stereotac-
tic radiosurgery. Tech Neurosurg 8:56–64, 2003
30. Salvant JB Jr, Young HF: Giant intrasacral schwannoma: an un-
usual cause of lumbrosacral radiculopathy. Surg Neurol 41:
411–413, 1994
31. Santi MD, Mitsunaga MM, Lockett JL: Total sacrectomy for a
giant sacral schwannoma. A case report. Clin Orthop 294:
285–289, 1993
32. Scheithauer B, Woodruff J, Erlandson R: Atlas of Tumor
Pathology. Tumors of the Peripheral Nervous System, ed 3,
fascicle 24. Washington, DC: Armed Forces Institute of Path-
ology, 1999, pp 105–415
33. Shikata J, Yamamuro T, Kotoura Y, et al: Total sacrectomy and
reconstruction for primary tumors. J Bone Joint Surg Am 70:
122–125, 1988
34. Smith PH, Ballantyne B: The neuroanatomical basis for dener-
vation of the urinary bladder following major pelvic surgery.
Br J Surg 55:929–933, 1968
35. Stener B, Gunterberg B: High amputation of the sacrum for ex-
tirpation of tumors. Principles and technique. Spine 3:351–366,
1978
36. Stewart RJ, Humphreys WG, Parks TG: The presentation and
management of presacral tumours. Br J Sug 73:153–155, 1986
37. Topsakal C, Erol FS, Ozercan I, et al: Presacral solitary giant
neurofibroma without neurofibromatosis type 1 presenting as
pelvic mass—case report. Neurol Med Chir 41:620–625, 2001
38. Turk PS, Peters N, Libbey NP, et al: Diagnosis and manage-
ment of giant intrasacral schwannoma. Cancer 70:2650–2657,
1992
39. Turner ML, Mulhern CB, Dalinka MK: Lesions of the sacrum.
Differential diagnosis and radiological evaluation. JAMA 245:
275–277, 1981
40. Whittaker LD, Pemberton JD: Tumors ventral to the sacrum.
Ann Surg 107:96–106, 1938
41. Wuisman P, Harle A, Matthiass H, et al: Two-stage therapy in
the treatment of sacral tumors. Arch Orthop Trauma Surg
108:255–260, 1989
42. Xu WP, Song XW, Yue SY, et al: Primary sacral tumors and
their surgical treatment. A report of 87 cases. Chin Med J 103:
879–884, 1990
Manuscript received June 2, 2003.
Accepted in final form July 3, 2003.
Address reprint requests to: Meic H. Schmidt, M.D., Department
of Neurosurgery, University of Utah, 30 North 1900 East, Suite
3B-409 SOM, Salt Lake City, Utah 84132-2303. email:
meic.schmidt@hsc.utah.edu
P. Klimo, et al.
6 Neurosurg. Focus / Volume 15 / August, 2003
